Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Post by Hankerchiefon Jul 18, 2019 2:21pm
117 Views
Post# 29935856

Already built into share price?

Already built into share price?The way things are going and the stock is acting I wonder if news of the first patient treated is already built into the share price.  Same goes with fda blessings.  It almost seems like the only way we will see a dramatic increase in share price is if something drastic and surprising happens.....like some sort of angel financing or right to try waiver or aggressive start of GBM trial/treatment/approval....something crazy and unexpected.  Heck it seems as if even a positive phase 2 bladder cancer trial is expected by most (and hopefully will come through) so could it be built into the price already?  Too many things were supposed to make the price go up and have shorts covering and running for the hills, etc...but to no avail.  What nugget is going to rocket this forward?  Does it have to be something unexpected?
Bullboard Posts